Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01445717 · ClinicalTrials.gov registry record
Rapid Diagnostic Test for Detection of Group B Streptococcus in Pregnancy
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 358
- Enrollment target
NCT01445717: Completed study, sponsored by The University of Texas Health Science Center, Houston.
NCT01445717 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 358 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01445717 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 358 participants
- Enrollment target
Study Summary
This study evaluates the use of a new method of growing and detecting Group B streptococcus in pregnant women. This new method utilizes sandwiched-membrane petri technology and has the advantage of detecting GBS in less than 6 hours, with less cost, and the potential of allowing antibiotic sensitivities to be performed.
Primary Outcome
Rapid assay results will be compared to routine culture results.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 358 participants |
| Start Date | 2010-11 |
| Est. Completion | 2012-12 |
What the finished NCT01445717 record still lists
NCT01445717 is an observational study that tracks outcomes without assigning an intervention. The registered 358 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01445717 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01445717 about?
NCT01445717 is a clinical study titled "Rapid Diagnostic Test for Detection of Group B Streptococcus in Pregnancy". This study evaluates the use of a new method of growing and detecting Group B streptococcus in pregnant women. This new method utilizes sandwiched-membrane petri technology and has the advantage of detecting GBS in less than 6 hours, with less cost, and the potential of allowing antibiotic sensitivi...
What is the current status of trial NCT01445717?
This trial is currently completed. The enrollment target is 358 participants. The study started on 2010-11. Estimated completion is 2012-12.
Who is sponsoring clinical trial NCT01445717?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04373317 · 358 participants · Phase 4
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
- NCT05684965 · 358 participants · Phase 1
XTX301 in Patients With Advanced Solid Tumors
- NCT05824975 · 358 participants · Phase 1
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- NCT06480227 · 358 participants · NA
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia